Literature DB >> 8280921

VIP gene expression in rat thymus and spleen.

R P Gomariz1, M Delgado, J R Naranjo, B Mellström, A Tormo, F Mata, J Leceta.   

Abstract

Vasoactive intestinal peptide (VIP) is a neuropeptide with immunomodulatory properties. In the present study, we demonstrate VIP gene expression in cells of both thymus and spleen in the rat by in situ hybridization. In thymus sections, hybridization signal for VIP mRNA was found in cells in corticomedullary and medulla regions. In the spleen, cells were labeled at the outer area on the periarteriolar lymphoid sheath of the white pulp. Hybridization signal appeared to be in lymphoid cells. These findings suggest that lymphoid cells might produce VIP, which, if released, could exert a paracrine action on central and peripheral lymphoid organs. We suggest that VIP participates in the bidirectional communication between the nervous and the immune systems.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8280921     DOI: 10.1006/brbi.1993.1027

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  7 in total

1.  Absence of vasoactive intestinal peptide expression in hematopoietic cells enhances Th1 polarization and antiviral immunity in mice.

Authors:  Jian-Ming Li; Lauren Southerland; Mohammad S Hossain; Cynthia R Giver; Ying Wang; Kasia Darlak; Wayne Harris; James Waschek; Edmund K Waller
Journal:  J Immunol       Date:  2011-06-15       Impact factor: 5.422

Review 2.  Regulation of VIP gene expression in general. Human lung cancer cells in particular.

Authors:  A Davidson; T W Moody; I Gozes
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

3.  Neuroimmune link in the mucosa of chronic gastritis with Helicobacter pylori infection.

Authors:  G Sipos; K Altdorfer; E Pongor; L P Chen; E Fehér
Journal:  Dig Dis Sci       Date:  2006-10       Impact factor: 3.199

4.  Pharmacological inhibition of VIP signaling enhances antiviral immunity and improves survival in murine cytomegalovirus-infected allogeneic bone marrow transplant recipients.

Authors:  Jian-Ming Li; Mohammad S Hossain; Lauren Southerland; Edmund K Waller
Journal:  Blood       Date:  2013-01-16       Impact factor: 22.113

Review 5.  VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair.

Authors:  J A Waschek
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

Review 6.  Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis.

Authors:  Yossan-Var Tan; James A Waschek
Journal:  ASN Neuro       Date:  2011-10-06       Impact factor: 4.146

Review 7.  A Clinical Approach for the Use of VIP Axis in Inflammatory and Autoimmune Diseases.

Authors:  Carmen Martínez; Yasmina Juarranz; Irene Gutiérrez-Cañas; Mar Carrión; Selene Pérez-García; Raúl Villanueva-Romero; David Castro; Amalia Lamana; Mario Mellado; Isidoro González-Álvaro; Rosa P Gomariz
Journal:  Int J Mol Sci       Date:  2019-12-20       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.